The 35 references in paper T. Tihomirova A., S. Lapin V., N. Tolkacheva F., Areg Totolian A., Т. Тихомирова А., С. Лапин В., Н. Толкачева Ф., Арег Тотолян А. (2014) “ВЗАИМОСВЯЗЬ АНТИТЕЛ К КЛЕТКАМ ОСТРОВКОВ ЛАНГЕРГАНСА С ОСТАТОЧНОЙ ФУНКЦИЕЙ ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ У БОЛЬНЫХ С САХАРНЫМ ДИАБЕТОМ 1 ТИПА // RELATION OF ISLET CELLS ANTIBODIES AND RESIDUAL FUNCTION OF PANCREAS IN PATIENTS WITH DIABETES TYPE I” / spz:neicon:mimmun:y:2005:i:1:p:41-48

1
Медицинские лабораторные технологии. Спра вочник в 2 х томах под ред. А.И. Карпищенко. – СПб.: Интермедика, 1999. – 655 с.
(check this in PDF content)
2
Особенности дебюта и прогноз сосудистых осложнений у больных медленнопрогрессирующим диабетом взрослых. Пособие для врачей / Под ред. Дедова И.И. – М., 2003. – с.38.
(check this in PDF content)
3
Петеркова В.А., Максимова В.П., Кураева Т.Л., Долгих А.С. Питание детей и подростков с сахарным диабетом. Пособие для родителей. – М., 2003. – с.65.
(check this in PDF content)
4
Смирнова О.М., Горелышева В.А., Дедов И.И. Характеристика фазы ремиссии при впервые выяв ленном инсулинзависимом сахарном диабете //Са харный диабет. – 1999. No1. – С. 16 21.
(check this in PDF content)
5
Amiel S.A., Caprio S., Sherwin R.S., Plewe G., Haymond M.W., Tamborlane W.V. Insulin resistance of puberty: a defect restricted to peripheral glucose me tabolism // J Clin Endocrinol Metab. – 1991. Feb; 72(2). – P.277 282.
(check this in PDF content)
6
Argoud G.M., Schade D.S., Eaton R.P. Insulin suppresses its own secretion in vivo // Diabetes. – 1987. – Vol. 36.– P. 959–962.
(check this in PDF content)
7
Arnold Larsen S., Madsbad S., Kuhl C. Repro ducibility of the glucagon test // Diabet Med. – 1987 . – Vol. 4.– P.299 303.
(check this in PDF content)
8
Aspinwall C.A., Lakey G.R.T., Kennedy R.T. In sulin stimulated insulin secretion in single pancreatic beta cells // J Biol Chem.– 1999.– Vol. 274, Issue 10, March 5 – P. 6360 6365.
(check this in PDF content)
9
Atkinson M.A., Leiter E.H. The NOD mouse mod el of type 1 diabetes: as good as it gets? // Nat.Med.– 1999 . – Vol. 5.– P. 601 604.
(check this in PDF content)
10
Bonora E., Coscelli C., Butturini U. Residual B cell function in type 1 (insulin dependent) diabetes mellitus: its relation to clinical and metabolic features // Acta Diabetol Lat.– . – Vol. 21.– P. 375 383.
(check this in PDF content)
11
Borg H., Marcus C., Sjoblad S., Fernlund P., Sun dkvist G. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibod ies after diagnosis of diabetes // Acta Paediatr.– 2000. – Vol. 89.– P. 46 –51.
(check this in PDF content)
12
Couper J.J., Hudson I., Werther G.A., Warne G.L., Court J.M., Harrison L.C. Factors predicting re sidual β cell function in the first year after diagnosis of childhood type 1 diabetes // Diabetes Res Clin Pract.– 1991. – Vol. 11.– P. 9–16.
(check this in PDF content)
13
Daneman D., Sochett E., Pak C.Y., Yoon J.W. Relationship of islet cell and islet cell surface antibod ies to the presentation and early course of IDDM in childhood // Diabetes Res Clin Pract.– 1988. . – Vol. 4(2), Jan 7– P. 127 132.
(check this in PDF content)
14
Decochez K., Keymeulen B., Somers G., Dorchy H., De Leeuw I., Mathieu C., Rottiers R., Winnock F., ver Elst K., Weets I., Pipeleers D., Gorus F., the Bel gian Diabetes Registry. Use of islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C peptide levels after clinical onset // Diabetolo gia.– 1999. – Vol. 42.– P. 62.
(check this in PDF content)
15
Decochez K., Tits J., Coolens J. L., Van Gaal L., Krzentowski G., Winnock F., Anckaert E., Weets I., Pipeleers D.G., Gorus F.K. High frequency of persist ing or increasing islet specific autoantibody levels af ter diagnosis of type 1 diabetes presenting before 40 years of age: the Belgian Diabetes Registry // Diabetes Care.– 2000. – Vol. 23.– P. 838 –844.
(check this in PDF content)
16
Diabetes Control and Complications Trial Re search Group. Effects of age, duration and treatment of insulin dependent diabetes mellitus on residual b cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT) // J Clin Endocrinol Metab.– 1987. – Vol. 65.– P. 30 36.
(check this in PDF content)
17
Gandullia E., Bonioli E., Monteverde R., La Fauci M.F., Lattere M., Augeri C., De Grandi R., Chiossi M., Alpigiani M.G. Significance of the evaluation of C pep tide in children with type 1 diabetes mellitus // Pedi atr Med Chir.– 1986. – Vol. 8(5).– P. 687 689.
(check this in PDF content)
18
Gottsater A., Landin Olsson M., Fernlund P., Lernmark A., Sundkvist G. B cell function in relation to islet cell antibodies (ICA) during the first three years after the clinical diagnosis of diabetes in non insulin dependent (type II) diabetic patients // Diabetes Care. –1993. – Vol. 16.– P. 902–910.
(check this in PDF content)
19
Hamalainen A.M., Ronkainen M.S., Akerblom H.K., Knip M. Postnatal elimination of transplacental ly acquired disease associated antibodies in infants born to families with type 1 diabetes // J. of Clinical Endo crinology & Metabolism.– 2000. – Vol. 85., No. 11 – P. 4249 4253.
(check this in PDF content)
20
Kolb H., Dannehl K., Gruneklee D., Zielasek J., Bertrams J., Hubinger A., Gries F.A. Prospective anal ysis of islet cell antibodies in children with type 1 (in sulin dependent) diabetes // Diabetologia.– 1988. – Vol. 31.– P. 189–194.
(check this in PDF content)
21
Komulainen J., Kulmala P., Savola K., Lounamaa R., Ilonen J., Reijonen H., Knip M., Akerblom H.K. Clinical, Autoimmune, and Genetic Characteristics of Very Young Children With Type 1 Diabetes // Diabe tes Care.– 1999. – Vol. 22.– P. 1950 1955.
(check this in PDF content)
22
Littorin B., Landin Olsson M., Lernmark A. An tibodies (ICA and GADA) at diagnosis of diabetes pre dict the subsequent need for insulin // Diabetes Care.– 1999. – Vol. 22.– P. 409 412.
(check this in PDF content)
23
Ludvigsson J., Binder C., Mandrup Poulsen T. Insulin autoantibodies are associated with islet cell antibodies; their relation to insulin antibodies and B cell function in diabetic children // Diabetologia. – 1988.– Vol. 31(9).– P. 647 651.
(check this in PDF content)
24
Marner B., Agner T., Binder C. Increased reduc tion in fasting C peptide is associated with islet cell an tibodies in type I (insulin dependent) diabetic patients // Diabetologia. – 1985. – Vol. 28. – P. 875–880.
(check this in PDF content)
25
Martin S., Wolf Eichbaum D., Duinkerken G., Scherbaum W.A., Kolb H., Noordzij J.G., Roep B.O. De velopment of type 1 diabetes despite severe hereditary B lymphocyte deficiency // N.Engl.J Med.– 2001. – Vol. 345.– P. 1036 1040.
(check this in PDF content)
26
Ronnemaa T. Practical aspects in performing the glucagon test in the measurement of C peptide secre tion in diabetic patients // Scand J Clin Lab Invest.– 1986. – Vol. 46.– P. 345 349.
(check this in PDF content)
27
Sabbah E., Savola K., Ebeling T. Genetic, Au toimmune, and Clinical Characteristics of Childhood and Adult Onset Type 1 Diabetes // Diabetes Care.– 2000. – Vol. 23.– P. 1326–1332.
(check this in PDF content)
28
Sabbah E., Savola K., Kulmala P., Veijola R., Va hasalo P., Karjalainen J., Еkerblom H.K., Knip M. Di abetes associated autoantibodies in relation to clinical characteristics and natural course in children with new ly diagnosed type 1 diabetes // J Clin Endocrinol Metab.– 1999. – Vol. 84.– P. 1534–1539.
(check this in PDF content)
29
Schiffrin A., Suissa S., Poussier P., Guttmann R., Weizner G. Prospective study of predictors of Я cell survival in type 1 diabetes // Diabetes. – 1988. – Vol. 37.– P. 920–925.
(check this in PDF content)
30
Schiffrin A., Suissa S., Weitzner G., Poussier P., La lla D. Factors predicting course of Я cell function in IDDM // Diabetes Care. – 1992. – Vol. 15.– P. 997–1001.
(check this in PDF content)
31
Sochett E.B., Daneman D., Clarson C., Ehrlich R.M. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin depen dent) diabetes mellitus in children // Diabetologia.– 1987. – Vol. 30.– P. 453–459.
(check this in PDF content)
32
Stassi G., Maria D.R., Trucco G., Rudert W., Tes ti R. Nitric Oxide Primes Pancreatic β Cells for Fas mediated Destruction in Insulin dependent Diabetes Mellitus // J. Exp. Med. – 1997. – Vol. 186. Number 8, October 20 – P. 1193 1200.
(check this in PDF content)
33
Torn C., Landin Olsson M., Lernmark A., Scher sten B., Ostman J., Arnqvist H.J., Bjork E., Blohme G., Bolinder J., Eriksson J., Littorin B., Nystrom L., Sund kvist G. Combinations of beta cell specific autoanti bodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage // Autoimmuni ty.– 2001. – Vol. 33.– P. 115 120
(check this in PDF content)
34
Wallensten M., Dahlquist G., Persson B. Fac tors influencing the magnitude, duration, and rate of fall of Я cell function in type 1 (insulin dependent) diabetic children followed for two years from their clin ical diagnosis // Diabetologia.– 1988. – Vol. 31.– P. 664–669.
(check this in PDF content)
35
Zamaklar M., Jotic A., Lalic N., Lalic K., Rajk ovic N., Milicic T. Relation between course of disease in type 1 diabetes and islet cell antibodies // Ann N Y Acad Sci. – 2002. – Vol. 958.– P.251 253. поступила в редакцию 10.11.2004
(check this in PDF content)